Table 2. Demographic Characteristics of People Screened in a Study Designed to Evaluate the Impact of Implementing HIV and HCV Screening in Community Pharmaciesa .
| Characteristic | Total screened (N = 1,164)b | Screened for HIV (n = 612) | Screened for HCV (n = 867) |
|---|---|---|---|
| Age, mean (SD), y | 44.9 (16.6) | 38.5 (13.9) | 46.5 (16.7) |
| Sex at birth, no. (%) | |||
| Female | 636 (54.6) | 307 (50.2) | 483 (55.7) |
| Male | 528 (45.4) | 305 (49.8) | 384 (44.3) |
| Previously tested, no. (%) | 430 (36.9)c | 166 (27.1)d | 264 (30.4)e |
Abbreviation: HCV, hepatitis C virus.
The study was conducted from July 2015 through August 2018. Sixty-one pharmacies participated in 3 US locations: Atlanta, Georgia; Detroit, Michigan; and Huntington/Charleston, West Virginia, along with Ohio communities neighboring the West Virginia border.
Some people were screened for both HIV and HCV.
Previously tested for either HIV or HCV.
Previously tested for HIV.
Previously tested for HCV.